HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Vaccination | Image credit: Prostock-studio - stock.adobe.com
HPV Vaccination Cost-Effective at Preventing Cervical Cancer in Patients With HIV

November 21st 2024

Women living with HIV can reduce their risk of cervical cancer using a human papillomavirus (HPV) vaccine that is both cost-effective and effective in preventing the virus.

HIV | Image credit: Corona Borealis - stock.adobe.com
New Data Provide Clearer Picture on Adherence to Lenacapavir

November 18th 2024

HIV | Image credit: RAJCREATIONZS - stock.adobe.com
BIC/FTC/TAF Effective at Virologic Suppression in HIV Presenting Late

November 15th 2024

Liver | Image credit: PIC4U - stock.adobe.com
Liver Steatosis, Fibrosis Highly Prevalent in People Living With HIV

November 12th 2024

Madalitso Juwayeyi
Empowering Young Women in the Fight Against HIV

November 8th 2024

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
November 22nd 2024

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

This Week in Managed Care: October 11, 2019
October 11th 2019

This Week in Managed Care: October 11, 2019

This week, the top managed care news included an effort by the Trump administration to bolster Medicare Advantage; an abortion case from Louisiana reached the Supreme Court; the study of adapting to changing oxygen levels wins the Nobel Prize.
California Becomes First State to Make HIV Prevention Medication Accessible Without a Prescription
October 9th 2019

California Becomes First State to Make HIV Prevention Medication Accessible Without a Prescription

Jaime Rosenberg
Once the bill goes into effect in January 2020, pharmacists will be able to provide pre-exposure prophylaxis for at least a 30-day supply and up to a 60-day supply and a complete course of post-exposure prophylaxis without a prescription.
What We're Reading: Juul Sued by School Districts; Virus Linked to Acute Flaccid Myelitis; HIV Prevention Drugs
October 8th 2019

What We're Reading: Juul Sued by School Districts; Virus Linked to Acute Flaccid Myelitis; HIV Prevention Drugs

AJMC Staff
E-cigarette manufacturer Juul is being sued by 3 school districts; virus linked as potential cause of acute flaccid myelitis; HIV prevention drugs will be available without prescription in California
FDA Approves Descovy for HIV Prevention in MSM, Transgender Women
October 3rd 2019

FDA Approves Descovy for HIV Prevention in MSM, Transgender Women

Jaime Rosenberg
The FDA has approved Gilead’s second HIV prevention pill, Descovy, for at-risk adults and adolescents weighing at least 35 kg, excluding those who are at risk of HIV due to vaginal sex because the efficacy of Descovy has not been assessed in this population.
Tuberculosis Preventive Therapy Heightens Risk of Adverse Outcomes in Pregnant Women With HIV
October 3rd 2019

Tuberculosis Preventive Therapy Heightens Risk of Adverse Outcomes in Pregnant Women With HIV

Jaime Rosenberg
The findings indicate that the initiation of tuberculosis preventive therapy isoniazid during pregnancy carries greater risk than initiation of the treatment during the postpartum period.
What We're Reading: Ending NY HIV Epidemic; Vaping-Related Lung Damage; Judge Clears Supervised Injection Drug Site
October 3rd 2019

What We're Reading: Ending NY HIV Epidemic; Vaping-Related Lung Damage; Judge Clears Supervised Injection Drug Site

AJMC Staff
New York Governor Andrew Cuomo said that the state is on track to meet its goal of ending the HIV/AIDS epidemic in New York by 2020; lung damage exhibited by some patients as a result of vaping resembles the damage on lungs exposed to chemical spills or harmful gases; a federal judge has ruled that a Philadelphia nonprofit’s plan to open a supervised injection drug site for drug users does not break federal law.
Observational Study Results Suggest Most HIV–HIV Kidney Transplants Have Long-term Success
October 3rd 2019

Observational Study Results Suggest Most HIV–HIV Kidney Transplants Have Long-term Success

Jaime Rosenberg
The study, which followed 51 people with HIV who received kidney transplants from deceased donors with HIV in South Africa, found that the transplants produced long-term success, with high rates of overall survival and kidney graft survival after 5 years.
Researchers Identify and Silence Long Noncoding RNA Responsible for HIV Replication
September 27th 2019

Researchers Identify and Silence Long Noncoding RNA Responsible for HIV Replication

Jaime Rosenberg
According to the researchers, the long noncoding RNA, when turned off or deleted, eliminates dormant HIV reservoirs that persist even when patients adhere here to their antiretroviral therapy regimen and are virally suppressed.
Researchers Identify Significant Prevalence of HIV-Transmitted Drug Resistance
September 26th 2019

Researchers Identify Significant Prevalence of HIV-Transmitted Drug Resistance

Jaime Rosenberg
Among 206 people visiting a county HIV clinic between 2006 and 2013, there was an overall 17.5% prevalence of transmitted drug resistance.
This Week in Managed Care: September 20, 2019
September 20th 2019

This Week in Managed Care: September 20, 2019

This week, the top managed care stories included Purdue Pharma filing for bankruptcy; new data showing the number of people who get screened for HIV at least once falls far short of what CDC recommends; findings that most US hospital markets are now highly concentrated.
Initiating Treatment in EDs Could Be Critical for Containing Spread of HIV
September 19th 2019

Initiating Treatment in EDs Could Be Critical for Containing Spread of HIV

Jaime Rosenberg
The researchers of the study argue that emergency departments (EDs) should not just be leveraged to diagnose HIV; they must also be proactive and initiate treatment, as well as facilitate follow-up case management and linkage to care outside of the ED.
HIV Associated With Significantly Increased Risk of Atrial Fibrillation
September 16th 2019

HIV Associated With Significantly Increased Risk of Atrial Fibrillation

Jaime Rosenberg
The researchers found that HIV significantly increases the risk of atrial fibrillation—a leading cause of stroke—at the same rate as or higher than known risk factors, including diabetes and hypertension.
How Many People Actually Get Screened for HIV?
September 14th 2019

How Many People Actually Get Screened for HIV?

Jaime Rosenberg
Using national electronic health record information on more than 40 million patients over a 20-year period, researchers have found that the proportion of Americans older than 18 years who have had a prior HIV test could be as low as 6.4%. However, they noted several limitations of their analysis.
People Living With HIV Face Significant Burden of Kidney Disease, Researchers Say
September 11th 2019

People Living With HIV Face Significant Burden of Kidney Disease, Researchers Say

Jaime Rosenberg
Cumulative viral load was associated with increased risk of kidney disease, suggesting that early viral suppression could decrease incidence of disease.
While Adherence to ART Regimens Has Improved Among People With HIV, Rates Remain Suboptimal
September 7th 2019

While Adherence to ART Regimens Has Improved Among People With HIV, Rates Remain Suboptimal

Jaime Rosenberg
The proportion of people living with HIV with more than 90% adherence to antiretroviral therapy (ART) increased from 33.5% in 2001 to 52.4% in 2010.
EMERALD Subgroup Analyses Demonstrate Safety, Efficacy of Switching Certain Patients With HIV to Symtuza
September 4th 2019

EMERALD Subgroup Analyses Demonstrate Safety, Efficacy of Switching Certain Patients With HIV to Symtuza

Jaime Rosenberg
New subgroup analyses from the phase 3 EMERALD trial are supporting the safety and efficacy of switching treatment-experienced, virally suppressed patients to the therapy.
Top 5 AJMC® Articles of August 2019
August 31st 2019

Top 5 AJMC® Articles of August 2019

Here are the top 5 articles for the month of August.
This Week in Managed Care: August 30, 2019
August 30th 2019

This Week in Managed Care: August 30, 2019

This week, the top managed care stories included a huge ruling against one opioid maker and a settlement offer from another; an expert panel calling for broader screening for hepatitis C; a review showing there are more fatal events linked to a multiple sclerosis drug than previously known.
People Living With HIV in New York City Still Dying From Infections, Not Just Old Age
August 30th 2019

People Living With HIV in New York City Still Dying From Infections, Not Just Old Age

Jaime Rosenberg
The researchers, who used autopsy reports of 252 people who died of AIDS in New York City between 1984 and 2016, found that infections associated with the virus are still the leading cause of death for the patient population in the state.
Understanding Disparities in HIV Outcomes to Drive Testing, Care Linkage Program Efforts
August 27th 2019

Understanding Disparities in HIV Outcomes to Drive Testing, Care Linkage Program Efforts

Jaime Rosenberg
Using 2 decades' worth of data, researchers were able to identify disparities in HIV outcomes across more than 25,000 people living with HIV in Tennessee.
Medicaid Expansion Linked to Increased HIV Testing
August 24th 2019

Medicaid Expansion Linked to Increased HIV Testing

Jaime Rosenberg
An analysis of data from between 2010 and 2017 found that Medicaid expansion promoted HIV testing without increasing HIV risk behavior among nonelderly adults.
Clinical Trial Participation Reduces Alcohol Intake, Improves HIV Outcomes in Women Regardless of Treatment Type
August 23rd 2019

Clinical Trial Participation Reduces Alcohol Intake, Improves HIV Outcomes in Women Regardless of Treatment Type

Jaime Rosenberg
Women participating in a randomized clinical trial were able to significantly reduce their alcohol intake regardless of medication assignment and subsequently improve rates of viral suppression.
FDA Panel Backs Use of Descovy for HIV Prevention in Men, Transgender Women
August 17th 2019

FDA Panel Backs Use of Descovy for HIV Prevention in Men, Transgender Women

Jaime Rosenberg
The panel voted against recommending the prevention pill for use in cisgender women due to inadequate data on efficacy in this patient population.
This Week in Managed Care: August 16, 2019
August 16th 2019

This Week in Managed Care: August 16, 2019

This week, the top managed care stories included the Trump administration looking to bar legal immigrants from using public benefits; a study in The American Journal of Managed Care® finding that a law to limit surprise medical bills is working; data on Affordable Care Act enrollment showing the effect of subsidies.
AJMC® in the Press, August 16, 2019
August 16th 2019

AJMC® in the Press, August 16, 2019

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Opioid Injection in Rural Areas Presents a Challenge to Ending HIV Epidemic in US
August 13th 2019

Opioid Injection in Rural Areas Presents a Challenge to Ending HIV Epidemic in US

Jaime Rosenberg
The viewpoint paints a picture of a challenge that is 2-fold: a growing amount of people are injecting opioids in rural communities, which is an emerging risk factor for HIV transmission, and these communities often lack the infrastructure or resources to prevent, diagnose, and treat HIV.
Researchers Say They Developed an Approach to Further Suppress HIV Infection
August 9th 2019

Researchers Say They Developed an Approach to Further Suppress HIV Infection

Jaime Rosenberg
Researchers found that they were able to use a small molecule called ZL0580 to modify bromodomain-containing protein 4 to suppress HIV.
For Children Born With HIV, Medication Adherence, Viral Suppression Decreases With Age
August 6th 2019

For Children Born With HIV, Medication Adherence, Viral Suppression Decreases With Age

Jaime Rosenberg
From preadolescence to young adulthood, the rate of self-reported nonadherence increased from 31% to half of study participants. Concurrently, the prevalence of a detectable viral load increased from 16% to 40%.
What We're Reading: Pay-to-Play Clinical Trials; Acting on US Drug Import Plan; HIV Provider Shortage
August 6th 2019

What We're Reading: Pay-to-Play Clinical Trials; Acting on US Drug Import Plan; HIV Provider Shortage

AJMC Staff
Federal regulators have caught on to a growing trend of clinical trials asking participants to pay to enroll; Canada's main pharmaceutical lobby group is asking the government to respond to US drug importation plans before Canada experiences drug shortages; with more HIV incidence than any other region, the South is turning to telemedicine to treat people living with the infection.
Among Elderly Patients With Cancer, Those With HIV Fare Worse Even After Adjusting for Treatment Variation
August 1st 2019

Among Elderly Patients With Cancer, Those With HIV Fare Worse Even After Adjusting for Treatment Variation

Jaime Rosenberg
A study published today in JAMA Oncology found that higher cancer mortality rates among people living with HIV remain even after adjusting for variations in cancer treatment, especially in breast and prostate cancers.
<1
...
141516171819202122
...
30>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo